PURPOSE: The purpose of this study was to introduce nurse-delivered intravitreal injections to increase medical retina treatment capacity. METHODS: Indemnity, clinical governance, training, planning, and implementation issues were addressed. The outcome measures were patient safety, patient experience, and clinic capacity. RESULTS: No serious vision-threatening complications were recorded in a consecutive series of 4000 nurse-delivered intravitreal injections. A Mann-Whitney test showed a significant increase in intravitreal injections (P=0.003) in the medical retina service after introduction of nurse-delivered intravitreal injections. The majority of patients accepted and were satisfied with a nurse-delivered intravitreal injection. DISCUSSION: Nurse-delivered intravitreal injections appear safe, acceptable to patients, and are an effective means to increase intravitreal injection capacity in medical retina clinics.
PURPOSE: The purpose of this study was to introduce nurse-delivered intravitreal injections to increase medical retina treatment capacity. METHODS: Indemnity, clinical governance, training, planning, and implementation issues were addressed. The outcome measures were patient safety, patient experience, and clinic capacity. RESULTS: No serious vision-threatening complications were recorded in a consecutive series of 4000 nurse-delivered intravitreal injections. A Mann-Whitney test showed a significant increase in intravitreal injections (P=0.003) in the medical retina service after introduction of nurse-delivered intravitreal injections. The majority of patients accepted and were satisfied with a nurse-delivered intravitreal injection. DISCUSSION: Nurse-delivered intravitreal injections appear safe, acceptable to patients, and are an effective means to increase intravitreal injection capacity in medical retina clinics.
Authors: Cristina A Augood; Johannes R Vingerling; Paulus T V M de Jong; Usha Chakravarthy; Johan Seland; Gisele Soubrane; Laura Tomazzoli; Fotis Topouzis; Graham Bentham; Mati Rahu; Jesus Vioque; Ian S Young; Astrid E Fletcher Journal: Arch Ophthalmol Date: 2006-04
Authors: J DaCosta; R Hamilton; J Nago; A Mapani; E Kennedy; T Luckett; C Pavesio; D Flanagan Journal: Eye (Lond) Date: 2014-11-21 Impact factor: 3.775
Authors: J C Buchan; W Amoaku; B Barnes; A Cassels-Brown; B Y Chang; J Harcourt; D Shickle; A F Spencer; S A Vernon; C MacEwen Journal: Eye (Lond) Date: 2017-06-16 Impact factor: 3.775
Authors: Omer Trivizki; Michael R Karp; Anuj Chawla; Justin Yamanuha; Giovanni Gregori; Philip J Rosenfeld Journal: Am J Ophthalmol Date: 2020-07-02 Impact factor: 5.258